Quantitative spinal cord MRI in MOG-antibody disease, neuromyelitis optica and multiple sclerosis

RECOMMENDED

Multiple Sclerosis

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

Lancet Neurol.

Ciccarelli O, Cohen JA, Reingold SC, Weinshenker BG; International Conference on Spinal Cord Involvement and Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders

doi: 10.1016/S1474-

Multiple Sclerosis

Spinal cord volume loss: A marker of disease progression in multiple sclerosis

Neurology.

Tsagkas C, Magon S, Gaetano L, Pezold S, Naegelin Y, Amann M, Stippich C, Cattin P, Wuerfel J, Bieri O, Sprenger T, Kappos L, Parmar K

doi: 10.1212/

Multiple Sclerosis

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

Brain

Barro C, Benkert P, Disanto G, Tsagkas C, Amann M, Naegelin Y, Leppert D, Gobbi C, Granziera C, Yaldizli Ö, Michalak Z, Wuerfel J, Kappos L, Parmar K, Kuhle J

doi: 10.1093/brain/awy154.

RECOMMENDED

Multiple Sclerosis

Peripheral CD19⁺ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders

J Neurol.

Ellrichmann G, Bolz J, Peschke M, Duscha A, Hellwig K, Lee DH, Linker RA, Gold R, Haghikia A

doi: 10.1007/s00415-018-9092-4.

RECOMMENDED

Further Publications NeurologyFurther Publications Psychiatry

Brain and cord imaging features in neuromyelitis optica spectrum disorders

Ann Neurol.

Cacciaguerra L, Meani A, Mesaros S, Radaelli M, Palace J, Dujmovic-Basuroski I, Pagani E, Martinelli V, Matthews L, Drulovic J, Leite MI, Comi G, Filippi M, Rocca MA

doi: 10.1002/ana.25411.

Multiple Sclerosis

Preferential spinal cord volume loss in primary progressive multiple sclerosis

Mult Scler.

Tsagkas C, Magon S, Gaetano L, Pezold S, Naegelin Y, Amann M, Stippich C, Cattin P, Wuerfel J, Bieri O, Sprenger T, Kappos L, Parmar K

doi: 10.1177/1352458518775006.

Multiple Sclerosis

The current role of MRI in differentiating multiple sclerosis from its imaging mimics

Nat Rev Neurol.

Geraldes R, Ciccarelli O, Barkhof F, De Stefano N, Enzinger C, Filippi M, Hofer M, Paul F, Preziosa P, Rovira A, DeLuca GC, Kappos L, Yousry T, Fazekas F, Frederiksen J, Gasperini C, Sastre-Garriga J, Evangelou N, Palace J

doi: 10.1038/nrneurol.2018.14.

SPECIAL REPORT

Multiple Sclerosis

Vaccination Readiness in Multiple Sclerosis

Multiple Sclerosis

Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis

Mult Scler.

Sotirchos ES, Gonzalez-Caldito N, Dewey BE, Fitzgerald KC, Glaister J, Filippatou A, Ogbuokiri E, Feldman S, Kwakyi O, Risher H, Crainiceanu C, Pham DL, Van Zijl PC, Mowry EM, Reich DS, Prince JL, Calabresi PA, Saidha S

doi: 10.1177/

Related content

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

Spinal cord volume loss: A marker of disease progression in multiple sclerosis

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders

Brain and cord imaging features in neuromyelitis optica spectrum disorders

Preferential spinal cord volume loss in primary progressive multiple sclerosis

The current role of MRI in differentiating multiple sclerosis from its imaging mimics

Vaccination Readiness in Multiple Sclerosis

Effect of disease-modifying therapies on subcortical gray matter atrophy in multiple sclerosis

Peripheral CD19⁺ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders